BioCatalystWatch
XLOWorkspace / XLO / OverviewCompany library
Xilio Therapeutics, Inc. logo

Xilio Therapeutics, Inc.

Xilio Therapeutics, Inc. (XLO)

Website

Price
Market cap
Next catalystExpected 1H 2027Efarindodekin alfa — monotherapy · Phase 2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

XTX601

T-cell engager

CLDN18.2 × CD3

Upcoming / outlook

XTX701

T-cell engager

PSMA × STEAP1 × CD3 × CD2

Upcoming / outlook

CLDN18.2 (ATACR format)

CLDN18.2 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

CLDN18.2 (ATACR format)

CLDN18.2 × CD3

PreINDP1P2P3FilingApproved
Upcoming / outlook

XTX601

T-cell engager

CLDN18.2 × CD3

Upcoming / outlook

XTX701

T-cell engager

PSMA × STEAP1 × CD3 × CD2

Upcoming / outlook

Other pipelines

XTX501

PD-1 / IL-2

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

XTX602

CLDN18.2 × CD3 × CD2

Upcoming / outlook

XTX201

IL-2Rβ (CD122) × IL-2Rγ (CD132)

PreINDP1P2P3FilingApproved

Partner / License out

History / paused

CTLA-4

PreINDP1P2P3FilingApproved

CTLA-4

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

XLO PR & News

PR & News

XLO SEC archive